Share Twitter LinkedIn Facebook Email In this presentation from Lymphoma & Myeloma 2016, Dr. Kieron Dunleavy discusses the latest developments in the upfront and relapsed treatment settings of primary CNS lymphoma. Click to Earn CME Credit: http://bit.ly/2mFKBrY © 2016 Imedex, LLC.
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read
Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD Acute Lymphoblastic Leukemia 4 Mins Read
FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia Acute Lymphoblastic Leukemia 3 Mins Read